Bottom line
How much do XBI and BIPIX overlap?
28% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 15.2% of XBI's assets and 12.8% of BIPIX's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings XBI and BIPIX have in common
| Holding | % of XBI | % of BIPIX | Overlap |
|---|---|---|---|
| Apogee Therapeutics Inc | 1.49% | 1.29% | 1.29% |
| Twist Bioscience Corp | 1.41% | 1.08% | 1.08% |
| Oruka Therapeutics Inc | 1.38% | 1.20% | 1.20% |
| Kymera Therapeutics Inc | 1.36% | 1.05% | 1.05% |
| Praxis Precision Medicines Inc | 1.29% | 1.02% | 1.02% |
| Erasca Inc | 1.27% | 1.08% | 1.08% |
| Revolution Medicines Inc | 1.20% | 1.04% | 1.04% |
| CG oncology Inc | 1.20% | 1.03% | 1.03% |
| Dianthus Therapeutics Inc | 1.18% | 1.12% | 1.12% |
| Natera Inc | 1.16% | 0.99% | 0.99% |
| Cogent Biosciences Inc | 1.14% | 0.99% | 0.99% |
| Travere Therapeutics Inc | 1.13% | 0.95% | 0.95% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XBI
- State Street Global Advisors — 5.87%
- Moderna Inc — 1.41%
- Viking Therapeutics Inc — 1.30%
- Rhythm Pharmaceuticals Inc — 1.20%
- SELLAS Life Sciences Group Inc — 1.19%
- Vaxcyte Inc — 1.19%
- Cytokinetics Inc — 1.18%
- Scholar Rock Holding Corp — 1.16%
- Roivant Sciences Ltd — 1.16%
- Mirum Pharmaceuticals Inc — 1.16%
- Ultragenyx Pharmaceutical Inc — 1.14%
- Alkermes PLC — 1.11%
- Krystal Biotech Inc — 1.10%
Only in BIPIX
- N/a — 6.70%
- N/a — 5.15%
- N/a — 4.12%
- N/a — 4.12%
- N/a — 3.16%
- Agpxx — 2.40%
- N/a — 1.24%
- Spyre Therapeutics Inc — 1.04%
- Protagonist Therapeutics Inc — 1.03%
- Regeneron Pharmaceuticals Inc — 1.01%
- Arrowhead Pharmaceuticals Inc — 0.95%
- Roivant Sciences Ltd — 0.95%
- Relay Therapeutics Inc — 0.95%
Asset mix
| Asset type | XBI | BIPIX |
|---|---|---|
| Stocks | 99.9% | 78.4% |
| Repurchase agreements | — | 24.5% |
| Cash & short-term funds | 5.9% | 2.4% |
| Equity derivatives | 0.1% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | XBI | BIPIX |
|---|---|---|
| US | 100.8% | 98.3% |
| IE | 1.2% | 1.0% |
| BM | 1.2% | 1.0% |
| NL | 1.0% | 0.8% |
| CH | 1.0% | 0.8% |
| VG | 0.5% | 0.4% |
| KY | — | 0.2% |
| CA | 0.2% | 0.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do XBI and BIPIX overlap?
What stocks do XBI and BIPIX have in common?
Should I own both XBI and BIPIX?
Which holds more stocks, XBI or BIPIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.